Sun Pharma Q1 profit rises 27% to ₹2,895 crore as revenue grows over 10%

•Sun Pharma's Q1 net profit rose 27% to ₹2,895 crore, driven by lower exceptional charges and revenue growth.

•Revenue increased 10.5% to ₹15,299.88 crore, with sales excluding other operating revenue up 10.1% to ₹15,183.55 crore.

•India formulations sales grew 16% to ₹5,474.89 crore, while global innovative medicines sales rose 12.9% to $351 million.

•Basic and diluted EPS rose to ₹12.10 from ₹9.50.